Moxetumomab pasudotox and Prasterone (dehydroepiandrosterone, DHEA) vaginal
Determining the interaction of Moxetumomab pasudotox and Prasterone (dehydroepiandrosterone, DHEA) vaginal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: dehydroepiandrosterone
Brand name: Intrarosa, DHEA
Synonyms: Prasterone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Prasterone Vaginal
- Moxetumomab pasudotox-Prasugrel
- Moxetumomab pasudotox-Prasugrel Tablets
- Moxetumomab pasudotox-Pravachol
- Moxetumomab pasudotox-Pravastatin
- Moxetumomab pasudotox-Pravastatin Sodium
- Prasterone (dehydroepiandrosterone, DHEA) vaginal-Moxetumomab Pasudotox-tdfk
- Prasterone (dehydroepiandrosterone, DHEA) vaginal-Moxetumomab pasudotox-tdfk Intravenous
- Prasterone (dehydroepiandrosterone, DHEA) vaginal-Moxifloxacin
- Prasterone (dehydroepiandrosterone, DHEA) vaginal-Moxifloxacin (Systemic)
- Prasterone (dehydroepiandrosterone, DHEA) vaginal-Moxifloxacin Hydrochloride
- Prasterone (dehydroepiandrosterone, DHEA) vaginal-Moxifloxacin Injection